Canadian Government Drops Plans for Regulatory Factors and Mandatory Net Price Reporting
Planned amendments to Canada’s Patented Medicines Regulations were dropped this week, according to a statement from the Minister of Health. [...]
Examining the Canadian Drug Reimbursement Environment
The Canadian market holds many lucrative opportunities for Canadian manufacturers, but standards for approval and reimbursement are markedly different from [...]
Advertisement
